Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 4 | 2024 | 507 | 1.110 |
Why?
|
| Exercise Test | 2 | 2016 | 243 | 0.790 |
Why?
|
| Fellowships and Scholarships | 2 | 2024 | 324 | 0.700 |
Why?
|
| Education, Medical, Graduate | 2 | 2024 | 546 | 0.630 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2020 | 152 | 0.580 |
Why?
|
| Crowdsourcing | 1 | 2018 | 14 | 0.570 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2019 | 115 | 0.550 |
Why?
|
| Fibrinolytic Agents | 1 | 2019 | 200 | 0.520 |
Why?
|
| Acute Coronary Syndrome | 1 | 2020 | 245 | 0.520 |
Why?
|
| Aortic Diseases | 1 | 2019 | 189 | 0.500 |
Why?
|
| Periodicals as Topic | 1 | 2018 | 180 | 0.470 |
Why?
|
| Consensus | 1 | 2018 | 565 | 0.470 |
Why?
|
| Pediatrics | 2 | 2024 | 1231 | 0.450 |
Why?
|
| Ventricular Dysfunction | 1 | 2015 | 27 | 0.450 |
Why?
|
| Heart Defects, Congenital | 6 | 2026 | 1894 | 0.430 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 536 | 0.420 |
Why?
|
| Thrombosis | 1 | 2019 | 495 | 0.420 |
Why?
|
| Coronary Angiography | 2 | 2016 | 457 | 0.420 |
Why?
|
| Heart Septal Defects | 3 | 2018 | 45 | 0.400 |
Why?
|
| Fontan Procedure | 1 | 2016 | 189 | 0.400 |
Why?
|
| Down Syndrome | 1 | 2016 | 233 | 0.390 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 310 | 0.390 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2016 | 276 | 0.380 |
Why?
|
| Tachycardia, Ventricular | 1 | 2015 | 254 | 0.360 |
Why?
|
| Arterial Pressure | 1 | 2012 | 131 | 0.360 |
Why?
|
| Education, Distance | 2 | 2024 | 69 | 0.350 |
Why?
|
| Hypertension, Pulmonary | 2 | 2016 | 463 | 0.350 |
Why?
|
| Chest Pain | 1 | 2012 | 125 | 0.350 |
Why?
|
| Heart Ventricles | 1 | 2016 | 769 | 0.340 |
Why?
|
| Electrocardiography | 1 | 2016 | 983 | 0.320 |
Why?
|
| Echocardiography | 4 | 2020 | 1138 | 0.300 |
Why?
|
| Pulmonary Artery | 1 | 2012 | 441 | 0.290 |
Why?
|
| Heart Diseases | 1 | 2012 | 505 | 0.270 |
Why?
|
| Child | 13 | 2026 | 26299 | 0.260 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 991 | 0.240 |
Why?
|
| LIM Domain Proteins | 2 | 2014 | 67 | 0.200 |
Why?
|
| Humans | 23 | 2026 | 131671 | 0.180 |
Why?
|
| Heart Murmurs | 1 | 2021 | 13 | 0.180 |
Why?
|
| Heart Failure | 1 | 2015 | 2307 | 0.180 |
Why?
|
| Job Application | 1 | 2021 | 21 | 0.170 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2021 | 84 | 0.160 |
Why?
|
| Brain Infarction | 1 | 2020 | 28 | 0.160 |
Why?
|
| Physical Examination | 1 | 2021 | 169 | 0.160 |
Why?
|
| Myxoma | 1 | 2020 | 29 | 0.160 |
Why?
|
| DiGeorge Syndrome | 1 | 2020 | 81 | 0.160 |
Why?
|
| Clinical Competence | 3 | 2024 | 1052 | 0.160 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 145 | 0.160 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2018 | 1170 | 0.150 |
Why?
|
| Infant | 6 | 2026 | 13306 | 0.150 |
Why?
|
| Career Choice | 1 | 2021 | 162 | 0.150 |
Why?
|
| Hospitals, Pediatric | 2 | 2016 | 794 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 635 | 0.150 |
Why?
|
| Male | 10 | 2026 | 65264 | 0.150 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 107 | 0.150 |
Why?
|
| Tetralogy of Fallot | 1 | 2020 | 176 | 0.140 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 206 | 0.140 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2018 | 133 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2019 | 214 | 0.130 |
Why?
|
| Learning | 1 | 2020 | 369 | 0.130 |
Why?
|
| Thrombolytic Therapy | 1 | 2019 | 207 | 0.130 |
Why?
|
| Aortic Valve | 1 | 2020 | 460 | 0.130 |
Why?
|
| Retrospective Studies | 7 | 2020 | 17667 | 0.130 |
Why?
|
| Internship and Residency | 3 | 2024 | 1215 | 0.130 |
Why?
|
| Aorta | 1 | 2020 | 529 | 0.130 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 1911 | 0.130 |
Why?
|
| Infant, Newborn | 5 | 2026 | 8589 | 0.130 |
Why?
|
| Risk Factors | 4 | 2018 | 10959 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 403 | 0.120 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 1405 | 0.120 |
Why?
|
| Adolescent | 5 | 2026 | 20982 | 0.110 |
Why?
|
| Vascular Resistance | 1 | 2016 | 182 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2021 | 556 | 0.110 |
Why?
|
| Seizures | 1 | 2020 | 889 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 201 | 0.110 |
Why?
|
| Female | 11 | 2026 | 71181 | 0.110 |
Why?
|
| Muscle, Striated | 1 | 2014 | 9 | 0.110 |
Why?
|
| Enalapril | 1 | 2014 | 13 | 0.110 |
Why?
|
| Captopril | 1 | 2014 | 23 | 0.110 |
Why?
|
| Muscle Proteins | 2 | 2014 | 404 | 0.100 |
Why?
|
| ROC Curve | 1 | 2016 | 615 | 0.100 |
Why?
|
| Airway Obstruction | 1 | 2016 | 177 | 0.100 |
Why?
|
| Myocarditis | 1 | 2015 | 130 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1078 | 0.100 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 217 | 0.090 |
Why?
|
| Texas | 2 | 2024 | 3621 | 0.090 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2012 | 41 | 0.090 |
Why?
|
| Angina Pectoris | 1 | 2012 | 57 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 2012 | 95 | 0.090 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 1 | 2012 | 45 | 0.090 |
Why?
|
| Palliative Care | 1 | 2016 | 444 | 0.090 |
Why?
|
| Heart Conduction System | 1 | 2012 | 161 | 0.090 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2015 | 481 | 0.080 |
Why?
|
| Graft Rejection | 1 | 2015 | 560 | 0.080 |
Why?
|
| Survival Rate | 1 | 2016 | 2151 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 4047 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 3917 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 5297 | 0.080 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 516 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 739 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2014 | 482 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2014 | 777 | 0.080 |
Why?
|
| Pacemaker, Artificial | 1 | 2011 | 194 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2012 | 407 | 0.070 |
Why?
|
| Referral and Consultation | 1 | 2012 | 566 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2015 | 832 | 0.070 |
Why?
|
| Brain | 1 | 2020 | 3239 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 1226 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2011 | 529 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2018 | 3130 | 0.070 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 673 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2297 | 0.060 |
Why?
|
| Age Factors | 1 | 2012 | 2872 | 0.060 |
Why?
|
| Young Adult | 2 | 2026 | 10104 | 0.060 |
Why?
|
| Ireland | 1 | 2024 | 32 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2018 | 12984 | 0.050 |
Why?
|
| Prognosis | 1 | 2012 | 4952 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2014 | 4683 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2026 | 15057 | 0.040 |
Why?
|
| Facial Paralysis | 1 | 2020 | 35 | 0.040 |
Why?
|
| Intracranial Embolism | 1 | 2020 | 25 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2020 | 94 | 0.040 |
Why?
|
| Mass Screening | 1 | 2026 | 825 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2020 | 88 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2018 | 3695 | 0.040 |
Why?
|
| Prevalence | 1 | 2026 | 2694 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 6279 | 0.040 |
Why?
|
| Cell Line | 2 | 2014 | 2605 | 0.040 |
Why?
|
| Tracheostomy | 1 | 2020 | 215 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2026 | 3834 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2018 | 359 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2020 | 974 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 549 | 0.030 |
Why?
|
| Reoperation | 1 | 2018 | 844 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2020 | 869 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 783 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1405 | 0.030 |
Why?
|
| Ankyrin Repeat | 1 | 2014 | 4 | 0.030 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2014 | 14 | 0.030 |
Why?
|
| Actinin | 1 | 2014 | 7 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 46 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2014 | 67 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2014 | 113 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 80 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1075 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 1224 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 421 | 0.020 |
Why?
|
| Protein Transport | 1 | 2014 | 362 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2012 | 10 | 0.020 |
Why?
|
| Connectin | 1 | 2012 | 28 | 0.020 |
Why?
|
| Naphthalenes | 1 | 2012 | 38 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 414 | 0.020 |
Why?
|
| Azepines | 1 | 2012 | 62 | 0.020 |
Why?
|
| Creatinine | 1 | 2014 | 402 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 279 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 1202 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 1217 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 1018 | 0.020 |
Why?
|
| Protein Binding | 1 | 2014 | 1712 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 6494 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2012 | 685 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1610 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2014 | 856 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 3460 | 0.020 |
Why?
|
| Kidney | 1 | 2012 | 1309 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 34374 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 6177 | 0.010 |
Why?
|
| Mice | 1 | 2014 | 18487 | 0.010 |
Why?
|